Start of Sales of Stainless Steel Materials for Injection Needles to Europe and China Compliant with the European Medical Device Regulations Cobalt Composition Regulations
NIPPON KINZOKU CO., LTD. (TOKYO: 5491) (Headquarters: Minato-ku, Tokyo) commercialized “NK-304LCO” stainless steel for injection needles in November 2020, which is compliant with the Cobalt composition regulation of the European Medical Devices Regulation (MDR), which came into effect in May 2021 and will be fully transitioned on 31 December 2028.
We would like to announce that we are currently making progress in expanding sales to overseas markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231101657356/en/
Stability of the welded part of the bare tube and cutting surface of the material, which will not rupture even when thinly drawn: The ratio between the fractured and sheared surfaces is agreed to facilitate welding by medical device manufacturers. The same end-face properties are supplied for the entire coil length (0.2 mm: approx. 4,000 M). (Graphic: Business Wire)
The MDR is a regulation for marketing medical devices in Europe and is a stricter approval system than the existing Medical Device Directive (MDD). The MDR stipulates the Regulation on Classification, Labeling and Packaging of substances and mixtures (CLP), which targets the cobalt (Co) component contained in stainless steel as a carcinogen. It is less than 0.1%.
Conventional NK-304NKM stainless steel for injection needles was difficult to adapt to this regulated quantity, but in response to requests from domestic and overseas medical device manufacturers, we have succeeded in alloy design (composition adjustment) as a result of discussions with raw material manufacturers. We were able to successfully supply the material.
Currently, we have started selling the amount equivalent to approximately 3% of the cobalt-regulated materials for customers using our stainless steel material for injection needles. The complete transition to MDR has been postponed from the original May 2024 to December 2028, volumes are currently increasing slightly due to the regulatory approach of individual medical manufacturers, but enquiries from the European and Chinese markets are increasing and sample shipments have already begun.
The NK-304NKM has been selected as the material of choice for "thin diameter" types of needles for insulin such as "painless needles" and cosmetic applications, and is currently being used all over the world. The sales share (*1) of our materials for injection needle applications is approximately 49% in Japan and 59% overseas (*2), with an average share of approximately 55%, and our quality superiority is widely recognized in the injection needle market. In addition to maintaining a high market share, sales to the Chinese and Indian markets are expected to expand in the future due to the increasing number of diabetes patients worldwide.
*1: 32 domestic and international companies, surveyed by us in October 2023.
*2: Overseas principal countries are South-East Asia, South Korea, China, India and the EU
Features of the NK-304LCO
Processability without rupture even at high drawing rate
Injection needles are manufactured by welding the edge of the material and then stretching the raw tube into a thin tube. For insulin, for example, a raw tube with a diameter of 4.0 mm and a wall thickness of 0.2 mm is drawn, then heat-treated and drawn many times in turn, until it is drawn to an outer diameter of 0.18 mm and a wall thickness of 0.05 mm. "Processability without rupture even when at high drawing rate" and "Stability of the welded part of the bare tube that does not fracture even when thinly drawn" are particularly important in this process.
Click here for the full text.
https://www.nipponkinzoku.co.jp/images/2023/10/91820e9f51d3ddb70d9857d1cacfef53-1.pdf
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231101657356/en/
Contact information
Sales Development Dept.
NIPPON KINZOKU CO., LTD.
E-mail: nikkin-overseas@nipponkinzoku.co.jp
https://www.nipponkinzoku.co.jp/en/inquiry
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Transition Industries LLC and Macquarie Group Announce Marketing Agreement for Low Carbon Methanol Project in Sinaloa, Mexico11.12.2023 15:13:00 CET | Press release
Transition Industries LLC announced at COP 28 that it has entered into a Master Services and Marketing Agreement (MSMA) with Macquarie Commodities Trading, an affiliate of Macquarie Group’s Commodities and Global Markets business (“Macquarie” / “CGM”), for its Pacifico Mexinol project, a 6,145 MT per day methanol production facility near Topolobampo, Sinaloa, Mexico (“Pacifico Mexinol” or the “Project”). When it commences operations, Pacifico Mexinol is expected to be one of the largest single low carbon chemicals facilities in the world - producing approximately 300,000 MT of green methanol from captured carbon and green hydrogen and 1.8 million MT of blue methanol per year from natural gas with carbon capture. Under the terms of the MSMA, Macquarie is responsible for marketing all the production from Pacifico Mexinol to customers on a global basis in accordance with methanol offtake agreements, the provisioning of financial hedging services as required by the Project, and supporting
SLB Collaborates with Northern Lights JV and Microsoft to Digitalize Carbon Capture and Storage Value Chain11.12.2023 15:00:00 CET | Press release
SLB (NYSE: SLB) and Northern Lights Joint Venture (NL) announced today they have signed a memorandum of understanding (MoU) with Microsoft to optimize integrated cloud-based workflows for the operation of Northern Lights, one of the first CO2 transport and storage providers for cross-border carbon capture and storage (CCS). The collaboration will contribute to the development of scalable and cost-efficient digital solutions for the emerging CCS industry. “Digital workflows are a key component to successfully managing CO2 through the end-to-end value chain, from capture point to permanent storage. Northern Lights is very pleased to partner with industry leading tech companies, SLB and Microsoft, on the development of digital CCS solutions”, said Børre Jacobsen, Managing Director of Northern Lights. In the initial phases of the collaboration, SLB will extend its digital CCS workflows and numerical simulation systems on its Delfi™ digital platform, which was deployed to streamline the sub
New Post Hoc Analysis from MAVORIC Trial Sheds Light on the Burden of Cutaneous T-Cell Lymphoma on Health-Related Quality of Life11.12.2023 15:00:00 CET | Press release
Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co. Ltd, today announced health-related quality of life (HRQL) findings from a post hoc analysis of the MAVORIC trial in patients with mycosis fungoides (MF) or Sézary syndrome (SS), two subtypes of cutaneous T-cell lymphoma (CTCL). Researchers analysed baseline data collected prior to initiation of study treatment and found the symptoms of advanced MF/SS affected HRQL across all domains, with poorer HRQL associated with being younger in age, female, having moderate or severe itching, and impaired function as measured by the Eastern Cooperative Oncology Group performance status (ECOG PS). “CTCL is a chronic, life-long condition. Understanding how symptoms impact an individual physically, emotionally as well as in their daily life is critical,” said Susan Thornton, Chief Executive Officer, Cutaneous Lymphoma Foundation and one of the study authors. “The data provide new insights into the burdens of living with CTC
Battery Manufacturer Hithium Opens New 28 GWh Intelligent Production Plant11.12.2023 15:00:00 CET | Press release
Stationary energy storage expert Hithium will release 28 GWh planned production capacity successively at first stage of Phase 1 of its new base in Chongqing, China. The new plant is designed in line with "Intelligent Manufacturing 4.0" standards, including a 26% increase in automation over the typical "Intelligent Manufacturing 3.0" production system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231211098435/en/ Hithium Chongqing production plant (Photo: Business Wire) Hithium’s automation gains at Chongqing have resulted in an overall efficiency jump of 30%, as well as cost reductions amounting to a quarter of production overhead, delivering a significant lead in manufacturing competitiveness. Built with an investment of RMB13 billion ($1.8 billion), the site covers 800,000 m2 and is located in the Tongliang high-tech zone. The new capacity aims at helping to meet global demand for what is expected to be 720GW of energy s
BIO KOREA 2024 Opens for Program Registration and Exhibition Applications11.12.2023 15:00:00 CET | Press release
BIO KOREA 2024, jointly hosted by the Korea Health Industry Development Institute (KHIDI, President: Cha Soon-do) and Chungcheongbuk-do (Governor: Kim Young-hwan), commenced entry registration and exhibition participating company recruitment from December 4, 2023. The event will be held at COEX in Seoul, Korea from May 8th to 10th, 2024. BIO KOREA, marking its 19th edition in 2024, has established itself as the preeminent bio-industry event in Korea. For the past 18 years, BIO KOREA has served as a catalyst for business revitalization and technological exchange between domestic and foreign companies, fostering a vibrant ecosystem of innovation and collaboration within the biohealth sector. Held in May of this year, BIO KOREA 2023 witnessed the participation of approximately 29,400 individuals from 780 companies across 51 countries, resulting in around 1,300 business meetings. Additionally, approximately 330 companies from 18 countries showcased their technologies through approximately